SBI Healthcare Opportunities Fund vs Tata India Pharma & Healthcare Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3933 Cr | ₹1296 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 32% | 26.49% |
Expense Ratio | 1.94 | 2.14 |
Manager | Pradeep Kesavan | Meeta Shetty |
ISIN Code | INF200K01446 | INF277K016A9 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -0.11% | -0.41% |
6 Month | 10.11% | 12.12% |
1 Year | 3.27% | -0.98% |
3 Year | 25.4% | 22.55% |
5 Year | 18.81% | 17.28% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 1.59% | 2.29% |
1 Year | 7.27% | 8.59% |
3 Year | 22.6% | 20.85% |
5 Year | 20.29% | 18.29% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 15.65% | 9.76% |
3 Year | 17.81% | 18.6% |
5 Year | 12.99% | 15.32% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.07% | 16.05% |
Sharp | 1.18% | 0.90% |
Beta | 0.84% | 0.98% |
Alpha | 3.58% | -0.49% |
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Pradeep Kesavan | Meeta Shetty |
Total AUM | ₹434274 Cr | ₹17847 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 13.76 | 4.61 |
Mid Cap | 27.24 | 35.03 |
Small Cap | 32.93 | 31.95 |
Large Cap | 26.07 | 28.41 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 3.85 | 2.56 |
Basic Materials | 5.79 | 1.44 |
Healthcare | 90.36 | 94.45 |
Financial Services | - | 1.56 |
Top Comparisons
ICICI Pru Nifty50 Value 20 Index Fund - Reg (G)
3Y Returns0%
Quant Value Fund Regular - Growth
3Y Returns22.16%
SBI Magnum Medium Duration Fund - Regular Plan - Growth
3Y Returns7.88%
UTI Medium Duration Fund - Regular Plan - Growth Option
3Y Returns7.18%
Invesco India Money Market Fund - Growth
3Y Returns7.25%
Tata Money Market Fund-Regular Plan - Growth Option
3Y Returns7.56%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns19.81%
HDFC Focused Fund - GROWTH PLAN
3Y Returns22.95%